- Home
- IRMD vs USPH Comparison
IRMD vs USPH Comparison
Compare IRMD & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRMD | USPH |
|---|---|---|
| Founded | 1992 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2014 | 1992 |
Fundamental Metrics
Financial Performance| Metric | IRMD | USPH |
|---|---|---|
| Price | $97.44 | $78.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $72.00 | ★ $106.50 |
| AVG Volume (30 Days) | 78.2K | ★ 161.9K |
| Earning Date | 02-12-2026 | 11-05-2025 |
| Dividend Yield | 0.70% | ★ 2.31% |
| EPS Growth | 13.00 | ★ 153.49 |
| EPS | 1.65 | ★ 2.38 |
| Revenue | $80,511,268.00 | ★ $750,948,000.00 |
| Revenue This Year | $15.17 | $19.53 |
| Revenue Next Year | $10.15 | $6.33 |
| P/E Ratio | $58.96 | ★ $32.86 |
| Revenue Growth | 12.91 | ★ 17.51 |
| 52 Week Low | $47.48 | $62.77 |
| 52 Week High | $98.53 | $93.50 |
Technical Indicators
Market Signals| Indicator | IRMD | USPH |
|---|---|---|
| Relative Strength Index (RSI) | 65.76 | 48.04 |
| Support Level | $90.92 | $79.10 |
| Resistance Level | $98.53 | $82.56 |
| Average True Range (ATR) | 2.27 | 2.46 |
| MACD | -0.41 | 0.19 |
| Stochastic Oscillator | 85.81 | 12.45 |
Price Performance
Historical ComparisonAbout IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.